KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Assets (2017 - 2026)

ClearPoint Neuro's Assets history spans 14 years, with the latest figure at $97.7 million for Q4 2025.

  • On a quarterly basis, Assets rose 149.42% to $97.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $97.7 million, a 149.42% increase, with the full-year FY2025 number at $97.7 million, up 149.42% from a year prior.
  • Assets hit $97.7 million in Q4 2025 for ClearPoint Neuro, up from $60.4 million in the prior quarter.
  • Over the last five years, Assets for CLPT hit a ceiling of $97.7 million in Q4 2025 and a floor of $30.1 million in Q1 2025.
  • Historically, Assets has averaged $56.9 million across 5 years, with a median of $56.6 million in 2022.
  • Biggest five-year swings in Assets: soared 214.87% in 2021 and later crashed 43.94% in 2025.
  • Tracing CLPT's Assets over 5 years: stood at $65.6 million in 2021, then decreased by 15.39% to $55.5 million in 2022, then fell by 23.12% to $42.7 million in 2023, then dropped by 8.14% to $39.2 million in 2024, then soared by 149.42% to $97.7 million in 2025.
  • Business Quant data shows Assets for CLPT at $97.7 million in Q4 2025, $60.4 million in Q3 2025, and $62.9 million in Q2 2025.